Paternal treatment with cisplatin impairs reproduction of adult male offspring in rats

Reproductive Toxicology

Volumn 32, Issue 4, 2011, Pages 425-433

  Favareto, Ana Paula Alves ^a   de Toledo, Fabíola Choqueta ^b   Kempinas, Wilma De Grava ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Adult male progeny; Cisplatin; Paternal exposure; Reproduction

Indexed keywords

CISPLATIN; TESTOSTERONE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREEDING; CONTROLLED STUDY; EPIDIDYMIS; FEMALE; FETUS; FETUS DEVELOPMENT; MALE; MALE FERTILITY; NONHUMAN; POSTNATAL DEVELOPMENT; POSTNATAL GROWTH; PROGENY; RAT; REPRODUCTIVE TOXICITY; SEXUAL DEVELOPMENT; SPERMATOGENESIS; TESTIS; TESTOSTERONE BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; EPIDIDYMIS; FEMALE; FERTILITY; FETAL DEVELOPMENT; MALE; ORGAN SIZE; PATERNAL EXPOSURE; PREGNANCY; RATS; RATS, WISTAR; REPRODUCTION; SEMINAL VESICLES; SEXUAL MATURATION; SPERM COUNT; SPERMATOGENESIS; TESTIS;

ANIMALIA; RATTUS;

EID: 80755159500     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2011.10.003     Document Type: Article

References (41)

1. Perreault S.D., Klinefelter G.R., Clegg E. Assessment of male reproductive toxicology. Principles and methods of toxicology 2008, 1605-1640. Informa Healthcare, New York. 5th ed. A.W. Hayes (Ed.).
2. Nassr A.C., Arena A.C., Toledo F.C., Bissacot D.Z., Fernandez C.D., Spinardi-Barbisan A.L., et al. Effects of gestational and lactational fenvalerate exposure on immune and reproductive systems of male rats. J Toxicol Environ Health A 2010, 73(13/14):952-964.
3. Scarano W.R., Toledo F.C., Guerra M.T., Pinheiro P.F., Domeniconi R.F., Felisbino S.L., et al. Functional and morphological reproductive aspects in male rats exposed to di-n-butyl phthalate (DBP) in utero and during lactation. J Toxicol Environ Health A 2010, 73(13/14):972-984.
4. Davis D.L., Friedler G., Mattison D., Morris R. Male-mediated teratogenesis and other reproductive effects: biologic and epidemiologic findings and a plea for clinical research. Reprod Toxicol 1992, 6(4):289-292.
5. Anderson A. Male-mediated developmental toxicity. Toxicol Appl Pharmacol 2005, 207:S506-S513.
6. Ahmad S. Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes. Chem Biodivers 2010, 7(3):543-566.
7. Kobrinsky N.L., Sposto R., Shah N.R., Anderson J.R., DeLaat C., Morse M., et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine and I-asparagine, maintenance chemotherapy, and transplantation: children's cancer group study CCG-5912. J Clin Oncol 2001, 19(9):2390-2396.
8. Einhorn L.H. Treatment of testicular cancer: a new and improved model. J Clin Oncol 1990, 8:1777-1781.
9. Einhorn L.H., Foster R.S. Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?. J Clin Oncol 2006, 24(16):2597-2598.
10. Cvitkovic E. Cumulative toxicities from cisplatin therapy and current cytoprotective measures. Cancer Treat Rev 1998, 24(4):265-281.
11. Sawhney P., Giammona C.J., Meistrich M.L., Richburg J.H. Cisplatin-induced long-term failure of spermatogenesis in adult C57/BI/6J mice. J Androl 2005, 26(1):136-145.
12. Ali B.H., Al-Moundhri M., Tageldin M., Al Husseini I.S., Mansour M.A., Nemmar A., et al. Ontogenic aspects of cisplatin-induced nephrotoxicity in rats. Food Chem Toxicol 2008, 46(11):3355-3359.
13. Lu Q.B., Kalantari S., Wang C.R. Electron transfer reaction mechanism of cisplatin with DNA at the molecular level. Mol Pharmacol 2007, 4(4):624-628.
14. Terheggen P.M.A.B., Floot B.G.J., Scherer E., Begg A.C., Fichtinger-Schepman A.M.J., den Engelse L. Immunocytochemical detection of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutane-decarboxylato) tissue sections. Cancer Res 1987, 47:6719-6725.
15. Hooser S.B., van Dijk-Knijnemburg W.C.M., Waalkens-Berendsen I.D.H., Smit-van Prooije A.E., Snoeij N., Baan R.A., et al. Cisplatin-DNA adduct formation in rat spermatozoa and its effect on fetal development. Cancer Lett 2000, 151:71-80.
16. Codrington A.M., Hales B.F., Robaire B. Spermiogenic germ cell phase-specific DNA damage following cyclophosphamide exposure. J Androl 2004, 25:354-362.
17. Zamble D.B., Mikata Y., Eng C.H., Sansman K.E., Lippard S.J. Testis-specific HMG-domain protein alters the responses of cells to cisplatin. J Inorg Biochem 2002, 91:451-462.
18. Poirier M.C., Reed E., Litterst C.L., Katz D., Gupta-Burt S. Persistence of platinum-amine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients. Cancer Res 1999, 52:149-153.
19. Kartalou M., Essigmann J.M. Recognition of cisplatin adducts by cellular proteins. Mutat Res 2001, 478:1-21.
20. Aitken R.J., De Iuliis G.N., McLachlan R.I. Biological and clinical significance of DNA damage in the male germ line. Int J Androl 2009, 32:46-56.
21. Ward W.S., Kishikawa H., Akutsu H., Yanagimachi H. Further evidence that sperm nuclear proteins are necessary for embryogenesis. Zygote 2000, 8:51-56.
22. Harrouk W., Khatabaksh S., Robaire B., Hales B.F. Paternal exposure to cyclophosphamide dysregulates the gene activation program in rat preimplantation embryos. Mol Reprod Dev 2000, 57:214-223.
23. Delbès G., Hales B.F., Robaire B. Effects of the chemotherapy cocktail used to treated testicular cancer on sperm chromatin integrity. J Androl 2007, 28(2):241-249.
24. Kinkead T., Flores C., Carboni A.A., Menon M., Seethalakshmi L. Short term effects of cis-platinum on male reproduction, fertility and pregnancy outcome. J Urol 1992, 47(1):201-206.
25. Seethalakshmi L., Flores C., Kinkead T., Carboni A.A., Malhotra R.K., Menon M. Effects of subchronic treatment with cis-platinum on testicular function, fertility, pregnancy outcome, and progeny. J Androl 1992, 13(1):65-74.
26. Marcon L., Hales B.F., Robaire B. Reversibility of the effects of subcronic exposure to the cancer chemotherapeutics, bleomycin, etoposide and cisplatin, on spermatogenesis, fertility, and progeny outcome in the male rat. J Androl 2008, 29(4):408-417.
27. Bieber A.M., Marcon L., Hales B.F., Robaire B. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility. J Androl 2006, 27(2):189-200.
28. Favareto A.P., Fernandez C.D., da Silva D.A., Anselmo-Franci J.A., Kempinas W.D. Persistent impairment of testicular histology and sperm motility in adult rats treated with cisplatin at peri-puberty. Basic Clin Pharmacol Toxicol 2011, 109(2):85-96.
29. Benedetto P. Chemotherapy of testis cancer. Cancer Control 1999, 6(6):549-559.
30. Bachmann K., Pardoe D., White D. Scaling basic toxicokinetic parameters from rat to man. Environ Health Perspect 1996, 104:400-407.
31. Nazian S.J. Serum concentrations of reproductive hormones after administration of various anesthetics to immature and young adult male rats. Proc Soc Exp Biol Med 1988, 187:482-487.
32. Flecknell P. Laboratory animal anesthesia 1996, Academic Press, London. 2th ed.
33. Gallavan R.H., Holson J.F., Stump D.G., Knapp J.F., Reynolds V.L. Interpreting the toxicologic significance of alterations in anogenital distance: potential for confounding effects of progeny body weights. Reprod Toxicol 1999, 13:383-390.
34. Robb G.W., Amann R.P., Killian G.J. Daily sperm production and epididymal sperm reserves of pubertal and adult rats. J Reprod Fertil 1978, 54(1):103-107.
35. Fernandes G.S., Arena A.C., Fernandez C.D., Mercadante A., Barbisan L.F., Kempinas W.G. Reproductive effects in male rats exposed to diuron. Reprod Toxicol 2007, 23(1):106-112.
36. Lirdi L.C., Stumpp T., Sasso-Cerri E., Miraglia S.M. Amifostine protective effect on cisplatin-treated rat testis. Anat Rec 2008, 291(7):797-808.
37. Trasler J.M., Hales B.F., Robaire B. A time-course study of chronic paternal cyclophosphamide treatment in rats: effects on pregnancy outcome and the male reproductive and hematologic systems. Biol Reprod 1987, 37(2):317-326.
38. Trasler J.M., Hales B.F., Robaire B. Chronic low dose cyclophosphamide treatment of adult male rats: effect on fertility, pregnancy outcome and progeny. Biol Reprod 1986, 34(2):275-283.
39. Fernandez C.D.B., Porto E.M., Arena A.C., Kempinas W.G. Effects of altered epididymal sperm transit time on sperm quality. Int J Androl 2007, 31:427-437.
40. Ricker D.D., Crone J.K., Chamness S.L., Klinefelter G.R., Chang T.S.K. Partial sympathetic denervation of the rat epididymis permits fertilization but inhibits embryo development. J Androl 1997, 18:131-138.
41. Kempinas W.G., Suarez J.D., Roberts N.L., Strader L., Ferrell J., Goldman J.M., et al. Fertility of rat epididymal sperm after chemically and surgically induced sympathectomy. Biol Reprod 1998, 59:897-904.